126 related articles for article (PubMed ID: 16513346)
1. Development of withaferin A analogs as probes of angiogenesis.
Yokota Y; Bargagna-Mohan P; Ravindranath PP; Kim KB; Mohan R
Bioorg Med Chem Lett; 2006 May; 16(10):2603-7. PubMed ID: 16513346
[TBL] [Abstract][Full Text] [Related]
2. Withaferin A is a potent inhibitor of angiogenesis.
Mohan R; Hammers HJ; Bargagna-Mohan P; Zhan XH; Herbstritt CJ; Ruiz A; Zhang L; Hanson AD; Conner BP; Rougas J; Pribluda VS
Angiogenesis; 2004; 7(2):115-22. PubMed ID: 15516832
[TBL] [Abstract][Full Text] [Related]
3. The tumor inhibitor and antiangiogenic agent withaferin A targets the intermediate filament protein vimentin.
Bargagna-Mohan P; Hamza A; Kim YE; Khuan Abby Ho Y; Mor-Vaknin N; Wendschlag N; Liu J; Evans RM; Markovitz DM; Zhan CG; Kim KB; Mohan R
Chem Biol; 2007 Jun; 14(6):623-34. PubMed ID: 17584610
[TBL] [Abstract][Full Text] [Related]
4. Small molecule anti-angiogenic probes of the ubiquitin proteasome pathway: potential application to choroidal neovascularization.
Bargagna-Mohan P; Ravindranath PP; Mohan R
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):4138-45. PubMed ID: 16936134
[TBL] [Abstract][Full Text] [Related]
5. Withaferin A effectively targets soluble vimentin in the glaucoma filtration surgical model of fibrosis.
Bargagna-Mohan P; Deokule SP; Thompson K; Wizeman J; Srinivasan C; Vooturi S; Kompella UB; Mohan R
PLoS One; 2013; 8(5):e63881. PubMed ID: 23667686
[TBL] [Abstract][Full Text] [Related]
6. The Use of Withaferin A to Study Intermediate Filaments.
Mohan R; Bargagna-Mohan P
Methods Enzymol; 2016; 568():187-218. PubMed ID: 26795472
[TBL] [Abstract][Full Text] [Related]
7. Antiplatelet, anticoagulant, and profibrinolytic activities of withaferin A.
Ku SK; Bae JS
Vascul Pharmacol; 2014 Mar; 60(3):120-6. PubMed ID: 24534482
[TBL] [Abstract][Full Text] [Related]
8. 2-Naphthoic acid ergosterol ester, an ergosterol derivative, exhibits anti-tumor activity by promoting apoptosis and inhibiting angiogenesis.
Lin M; Li H; Zhao Y; Cai E; Zhu H; Gao Y; Liu S; Yang H; Zhang L; Tang G
Steroids; 2017 Jun; 122():9-15. PubMed ID: 28377207
[TBL] [Abstract][Full Text] [Related]
9. Barrier protective effects of withaferin A in HMGB1-induced inflammatory responses in both cellular and animal models.
Lee W; Kim TH; Ku SK; Min KJ; Lee HS; Kwon TK; Bae JS
Toxicol Appl Pharmacol; 2012 Jul; 262(1):91-8. PubMed ID: 22561332
[TBL] [Abstract][Full Text] [Related]
10. The tumor proteasome is a primary target for the natural anticancer compound Withaferin A isolated from "Indian winter cherry".
Yang H; Shi G; Dou QP
Mol Pharmacol; 2007 Feb; 71(2):426-37. PubMed ID: 17093135
[TBL] [Abstract][Full Text] [Related]
11. A natural anti-inflammatory enone fatty acid inhibits angiogenesis by attenuating nuclear factor-κB signaling in vascular endothelial cells.
Furuno A; Watari K; Nakamura M; Fukunaga Y; Jung JH; Ono M
Int J Oncol; 2011 Feb; 38(2):493-501. PubMed ID: 21132269
[TBL] [Abstract][Full Text] [Related]
12. Withaferin A, a natural compound with anti-tumor activity, is a potent inhibitor of transcription factor C/EBPβ.
Falkenberg KD; Jakobs A; Matern JC; Dörner W; Uttarkar S; Trentmann A; Steinmann S; Coulibaly A; Schomburg C; Mootz HD; Schmidt TJ; Klempnauer KH
Biochim Biophys Acta Mol Cell Res; 2017 Jul; 1864(7):1349-1358. PubMed ID: 28476645
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological activity of (+)-hedychilactone A and its analogs from (+)-sclareolide.
Oh S; Jeong IH; Shin WS; Wang Q; Lee S
Bioorg Med Chem Lett; 2006 Mar; 16(6):1656-9. PubMed ID: 16384699
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis.
Haspel HC; Scicli GM; McMahon G; Scicli AG
Microvasc Res; 2002 May; 63(3):304-15. PubMed ID: 11969307
[TBL] [Abstract][Full Text] [Related]
15. Isogambogenic acid inhibits tumour angiogenesis by suppressing Rho GTPases and vascular endothelial growth factor receptor 2 signalling pathway.
Fan Y; Peng A; He S; Shao X; Nie C; Chen L
J Chemother; 2013 Oct; 25(5):298-308. PubMed ID: 24070138
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol inhibits TNF alpha-induced endothelial cell activation.
Bertelli AA; Baccalini R; Battaglia E; Falchi M; Ferrero ME
Therapie; 2001; 56(5):613-6. PubMed ID: 11806302
[TBL] [Abstract][Full Text] [Related]
17. Analyses of Titanocenes in the spheroid-based cellular angiogenesis assay.
Weber H; Claffey J; Hogan M; Pampillón C; Tacke M
Toxicol In Vitro; 2008 Mar; 22(2):531-4. PubMed ID: 17981007
[TBL] [Abstract][Full Text] [Related]
18. Production of reactive oxygen species by withaferin A causes loss of type collagen expression and COX-2 expression through the PI3K/Akt, p38, and JNK pathways in rabbit articular chondrocytes.
Yu SM; Kim SJ
Exp Cell Res; 2013 Nov; 319(18):2822-34. PubMed ID: 24016823
[TBL] [Abstract][Full Text] [Related]
19. Anti-angiogenic activity of the purine analog 6-thioguanine.
Presta M; Belleri M; Vacca A; Ribatti D
Leukemia; 2002 Aug; 16(8):1490-9. PubMed ID: 12145690
[TBL] [Abstract][Full Text] [Related]
20. LHT7, a chemically modified heparin, inhibits multiple stages of angiogenesis by blocking VEGF, FGF2 and PDGF-B signaling pathways.
Chung SW; Bae SM; Lee M; Al-Hilal TA; Lee CK; Kim JK; Kim IS; Kim SY; Byun Y
Biomaterials; 2015 Jan; 37():271-8. PubMed ID: 25453957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
